combination therapies outperforming semaglutide Obesity treatment is evolving rapidly, with newer medications now offering significant and sustained weight loss when combined with lifestyle modification. GLP-1 and dual GIP/GLP-1 such as and tirzepatide are currently Trial suggests GLP-1 combo therapy

Strive Pharmacy semaglutide for special populations Not every patient fits neatly into the standard titration schedule

Many pharmacies have pharmacists available to assess specific exposure scenarios and advise whether the medication is still suitable for use

Zhang L, et al

Diabetes Management It's interesting to note that some medications used for weight loss, like certain GLP-1 agonists, are also prescribed for managing type 2 diabetes

weight loss on semaglutide (Wegovy) presented for short interval mammographic follow-up of a right breast asymmetry (Fig

Clinical trials remain the gold standard for identifying drug safety issues